Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIqgeo Regulatory News (IQG)

Share Price Information for Iqgeo (IQG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.00
Bid: 462.00
Ask: 472.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.165%)
Open: 467.00
High: 467.00
Low: 467.00
Prev. Close: 467.00
IQG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

22 Jun 2017 10:51

RNS Number : 8776I
Ubisense Group PLC
22 June 2017
 

22 June 2017

 

Ubisense Group Plc

Directors' Dealings

Ubisense Group plc (LSE:UBI, "Company" or "Ubisense") received notification on 21 June 2017 from Kestrel Partners LLP ("Kestrel") that on 21 June 2017 it acquired, on behalf of its discretionary clients, 115,000 ordinary shares of 2p each ("Shares") in the Company at a price of £0.37 per share. The notification also included the matters set out below.

Kestrel is the investment manager to Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), and various other clients. This disclosure relates to indirect Shares and voting rights in the Company that are managed by Kestrel on a discretionary basis.

Mr Scott is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Ubisense.

Prior to this purchase of Shares, Kestrel on a combined basis indirectly held Shares and voting rights over 15,915,493 Shares in the Company.

Of the Shares purchased, 97,750 were acquired on behalf of Kestrel Opportunities and following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 11,855,785 Shares in the Company. The remaining 17,250 Shares were purchased on behalf of Kestrel's other discretionary clients, in which Mr Scott has no beneficial interest, who, following this transaction, hold a further 4,174,708 Shares in the Company.

Following this transaction and on a combined basis, Kestrel indirectly holds voting rights over 16,030,493 Shares in the Company, which represents approximately 28.69% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

11,855,785

21.22%

Indirect

JIM Nominees Limited

1,306,095

2.34%

Indirect

Bank of New York Nominees Ltd

2,868,613

5.13%

 

For further information contact:

 

Ubisense Group PLCPeter Harverson

Tim Gingell

 

+44 (0) 1223 535 170

Numis Securities LimitedSimon Willis

Jamie Lillywhite

Toby Adcock

+44 (0) 20 7260 1000

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHKMGZVLZGGNZG
Date   Source Headline
30th Apr 20154:35 pmRNSPrice Monitoring Extension
30th Apr 20157:00 amRNSTrading Statement
24th Apr 20153:58 pmRNSResult of AGM
26th Mar 20157:00 amRNSHolding(s) in Company
23rd Mar 20152:59 pmRNSDirector/PDMR Shareholding
18th Mar 20157:00 amRNSDirector/PDMR Shareholding
17th Mar 20157:00 amRNSFinal Results
21st Jan 20157:00 amRNSTrading Statement
12th Dec 20147:00 amRNSChange of Adviser
19th Nov 20142:00 pmRNSUbisense Enhances Smart Factory
31st Oct 20142:15 pmRNSTotal Voting Rights
27th Oct 20147:00 amRNSContract Win
3rd Oct 20142:32 pmRNSHolding(s) in Company
30th Sep 20147:00 amRNSTotal Voting Rights
16th Sep 20147:00 amRNSInterim Results
18th Aug 20147:00 amRNSUbisense Wins New European Deal
31st Jul 20147:00 amRNSTotal Voting Rights
22nd Jul 20147:00 amRNSContract Win
21st Jul 20147:00 amRNSHalf Year End Trading Update
30th Jun 20142:26 pmRNSTotal Voting Rights
30th Jun 20147:00 amRNSBlocklisting Interim Review
16th Jun 20147:00 amRNSUbisense wins Contract Extensions
29th May 20145:16 pmRNSGrant Of Options
27th May 20147:00 amRNSNon-Executive Director Changes
15th May 20144:08 pmRNSResult of AGM
15th May 20147:00 amRNSUbisense Wins $1m Order From US Network Operator
29th Apr 20143:40 pmRNSAdditional Listing
29th Apr 20147:00 amRNSAutomaker Makes Seventh Smart Factory Deployment
11th Apr 20147:00 amRNSNotice of AGM
7th Apr 20147:00 amRNSUbisense Wins $1.2m Software Order
4th Apr 20144:38 pmRNSTotal Voting Rights
2nd Apr 20142:49 pmRNSPlacing
31st Mar 20147:00 amRNSUbisense Smart Factory Order Extension
25th Mar 20147:00 amRNSPreliminary Results
26th Feb 20147:00 amRNSUbisense and Daifuku launch Smart Warehouse system
10th Feb 20147:00 amRNSAppointment of CFO
6th Feb 20147:00 amRNSUbisense Smart Factory System selected
21st Jan 20147:00 amRNSTrading Update
31st Dec 20137:00 amRNSTotal Voting Rights
20th Dec 20137:00 amRNSUbisense wins EUR4.5m order extension
16th Dec 20137:00 amRNSWins EUR5.3m order from German state land registry
3rd Dec 20137:00 amRNSAcquisition of Geoplan Interworks K.K.
26th Nov 20137:00 amRNSUbisense signs strategic partnership in Asia
21st Nov 20137:00 amRNSEuropean Auto adds fourth Smart Factory System
13th Nov 20137:01 amRNSLarge Auto OEM Extends Smart Factory System
13th Nov 20137:00 amRNSTrading Update
4th Nov 201312:06 pmRNSTotal Voting Rights
31st Oct 20137:00 amRNSUbisense wins North American Utility Contracts
15th Oct 20137:00 amRNSUbisense wins global auto OEM deal for US plants
30th Sep 20139:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.